| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.4M | -45.4% | +149.0% |
| R&D Expense | $28.9M | -28.6% | -42.9% |
| SG&A Expense | $13.2M | -16.8% | -21.0% |
| Operating Income | -$40.2M | +52.4% | +39.5% |
| Pre-tax Income | -$36.9M | +54.4% | +38.3% |
| Income Tax | -$371K | -100.8% | +55.6% |
| Net Income | -$36.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $330.8M | -10.9% | -36.3% |
| Current Assets | $340.0M | -11.8% | -36.5% |
| Total Assets | $352.6M | -11.6% | -40.8% |
| Current Liabilities | $51.4M | -24.1% | +10.8% |
| Total Liabilities | $57.6M | -22.9% | -5.3% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$140.3M | — | — |
| Investing Cash Flow | -$138K | — | — |
| Financing Cash Flow | -$139K | — | — |
| +70.9% |
| +38.1% |
| EPS (Basic) | -$0.68 | +70.9% | +38.2% |
| EPS (Diluted) | -$0.68 | +70.9% | +38.2% |
| $295.0M |
| -9.0% |
| -44.8% |